Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.4879

Epidermal Growth Factor Receptor-Related DNA Repair and Radiation-Resistance Regulatory Mechanisms: A Mini-Review  

Bai, Jing (Department of Radiotherapy, Bao Tou Tumor Hospital)
Guo, Xiao-Guang (Department of Head and Neck Surgical Oncology, Bao Tou Tumor Hospital)
Bai, Xiao-Ping (Department of Radiotherapy, Bao Tou Tumor Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 4879-4881 More about this Journal
Abstract
Epidermal growth factor receptor (EGFR) overexpression is associated with resistance to chemotherapy and radiotherapy. The EGFR modulates DNA repair after radiation-induced damage through an association with the catalytic subunit of DNA protein kinase. DNA double-strand breaks (DSBs) are the most lethal type of DNA damage induced by ionizing radiation, and non-homologous end joining is the predominant pathway for repair of radiation-induced DSBs. Some cell signaling pathways that respond to normal growth factors are abnormally activated in human cancer. These pathways also invoke the cell survival mechanisms that lead to resistance to radiation. The molecular connection between the EGFR and its control over DNA repair capacity appears to be mediated by one or more signaling pathways downstream of this receptor. The purpose of this mini-review was not only to highlight the relation of the EGFR signal as a regulatory mechanism to DNA repair and radiation resistance, but also to provide clues to improving existing radiation resistance through novel therapies based on the above-mentioned mechanism.
Keywords
Epidermal growth factor receptor; signal pathway; DNA-damage repair; radiation resistance;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ang KK, Mason KA, Meyn RE (2002). Epidermal growth factor receptor (EGFR) and its inhibition in radiotherapy; 7th International Meeting on Progress in Radio-OncologyICRO/PGRO; Salzburg, Austria: Medimond, Inc pp 557-67.
2 Toulany M, Rodemann HP (2010). Membrane receptor signaling and control of DNA repair after exposure toionizing radiation. Nuklearme Dizin, 49, S26-30.
3 Carracedo A, Pandolfi PP (2008). The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene, 27, 5527-41.   DOI   ScienceOn
4 Chen DJ, Nirodi CS (2007). The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res, 13, 6555-60.   DOI   ScienceOn
5 Fryknas M, Dhar S, Oberg F, et al (2007). STAT1 signaling is associated with acquired cross resistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer, 120, 189-95.   DOI
6 Golding SE, Morgan RN, Asams BR, et al (2009). Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther, 8, 730-8.   DOI
7 Hiro J, Inoue Y, Toiyama Y, Miki C, Kusunoki M (2008). Mechanism of resistance to chemoradiation in p53 mutant human colon cancer. Int J Oncol, 32, 1305-10.
8 Khodarev NN, Minn AJ, Efimova EV, et al (2007). Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res, 67, 9214-20.   DOI
9 Kriegs M, Kasten-Pisula U, Rieckmann T, et al (2010). The epidermal growth factor receptor modulates DNA doublestrand break repair by regulating non-homologous endjoining. DNA Repair (Amst), 9, 889-97.   DOI
10 Liccardi G, Hartley JA, Hochhauser D (2011). EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res, 71, 1103-14.   DOI
11 Meister N, Shalaby T, von Bueren AO, et al (2007). Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy. Eur J Cancer, 43, 1833-41.   DOI
12 Rodemann HP, Dittmann K, Toulany M (2007). Radiationinduced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol, 83, 781-91.   DOI   ScienceOn
13 Meyn RE, Munshi A, Haymach JV, Milas L, Ang KK (2009). Signaling as a regulatory mechanism of DNA repair. Radiother Oncol, 92, 316-22.   DOI   ScienceOn
14 Mukherjee B, Choy H, Nirodi C, Burma S (2010). Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization. Semin Radiat Oncol, 20, 250-7.   DOI
15 Ono M, Kuwano M (2006). Molecular mechanisms of epidermal growth factor receptor (EGFR) activationand response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res, 12, 7242-51.   DOI   ScienceOn
16 Sartor CI (2004). Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol, 1, 80-7.
17 Szumiel I (2006). Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. Cell Signal, 18, 1537-48.   DOI
18 Tanaka T, Munshi A, Brooks C, et al (2008). Gefitinibradiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity. Clin Cancer Res, 14, 1266-73.   DOI
19 Toulany M, Dittmann K, Fehrenbacher B, et al (2008). PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amst), 7, 1746-56.   DOI
20 Toulany M, Kehlbach R, Florczak U, et al (2008). Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther, 7, 1772-81.   DOI